Literature DB >> 14602572

Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites.

Margaret B Parr1, Earl L Parr.   

Abstract

Female mice have been used extensively to study mucosal immunity against herpes simplex virus type 2 (HSV-2) infection of the vagina, but comparatively little is known about the spread of this virus to other tissues. Here the authors have used immunolabeling to demonstrate that HSV-2 infected the vaginal epithelium; the epithelium covering the vulva, perineum, and anal canal; and perineal hair follicles and sebaceous glands. The kinetics and basal localization of the immunolabeling indicated that the virus spread horizontally within the epithelial layer, starting in the vagina and then proceeding to the distal epithelial sites. HSV-2 also spread from the vagina to multiple neuronal sites including the paracervical ganglia (PCG), which are the major autonomic ganglia of the pelvis. The authors demonstrated both sympathetic and parasympathetic neurons in the PCG by labeling of acetylcholinesterase and tryosine hydroxlyase, and noted that infection was limited mainly or entirely to parasympathetic neurons. Infection of the PCG was correlated with the presence of virus in the autonomic ganglia in the walls of the rectum and urinary bladder, which in turn correlated with distention of these organs and retention of urine and feces. HSV-2 infection was also detected in cell bodies and axons in the lumbosacral sympathetic chain, in lumbosacral dorsal root ganglia, and in the dorsal portions of the lumbar spinal cord. Collectively, the data show that vaginal HSV-2 infection in mice leads to subsequent infection of multiple neural and epithelial sites. This information should be useful for development of a mouse model that can be used to study HSV-2 latency and for development of therapeutic vaccines to prevent recurrent infections.

Entities:  

Mesh:

Year:  2003        PMID: 14602572     DOI: 10.1080/13550280390246499

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  37 in total

1.  Genital herpesvirus hominis infection in mice. I. Development of an experimental model.

Authors:  J C Overall; E R Kern; R L Schlitzer; S B Friedman; L A Glasgow
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Replication of herpes simplex virus type 1 and 2 in the medulla of the adrenal gland after vaginal infection of mice.

Authors:  J Podlech; F Hengerer; M Fleck; I Walev; D Falke
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2.

Authors:  N A Sanjuan; E F Lascano
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Experimental model for activation of genital herpes simplex virus.

Authors:  H Wrzos; F Rapp
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

5.  Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction.

Authors:  R Zawatzky; J Hilfenhaus; F Marcucci; H Kirchner
Journal:  J Gen Virol       Date:  1981-03       Impact factor: 3.891

6.  Projections of the guinea-pig paracervical ganglion to pelvic viscera.

Authors:  B S Mitchell; E Ahmed; V V Stauber
Journal:  Histochem J       Date:  1993-01

7.  Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes.

Authors:  M R McDermott; P L Brais; G C PLoettsche; M J Evelegh; C H Goldsmith
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Pathogenesis of HSV-1/2 induced vaginitis/vulvitis of the mouse: dependence of lesions on genetic properties of the virus and analysis of pathohistology.

Authors:  M Fleck; J Podlech; K Weise; H Müntefering; D Falke
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R Whitley; A Arvin; C Prober; L Corey; S Burchett; S Plotkin; S Starr; R Jacobs; D Powell; A Nahmias
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

10.  Central nervous system and genital infection with reactivation of latent herpes simplex virus type 2 in mice.

Authors:  J R Martin; E V Reed
Journal:  Microb Pathog       Date:  1986-04       Impact factor: 3.738

View more
  20 in total

1.  Stress Hormones Epinephrine and Corticosterone Selectively Modulate Herpes Simplex Virus 1 (HSV-1) and HSV-2 Productive Infections in Adult Sympathetic, but Not Sensory, Neurons.

Authors:  Angela M Ives; Andrea S Bertke
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Herpes Simplex Virus 1 Reactivates from Autonomic Ciliary Ganglia Independently from Sensory Trigeminal Ganglia To Cause Recurrent Ocular Disease.

Authors:  Sungseok Lee; Angela M Ives; Andrea S Bertke
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

3.  Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation.

Authors:  Julianna R Pieknik; Andrea S Bertke; Philip R Krause
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

4.  Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.

Authors:  Jill M Steinbach; Caroline E Weller; Carmen J Booth; W Mark Saltzman
Journal:  J Control Release       Date:  2012-06-15       Impact factor: 9.776

5.  The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.

Authors:  Kevin C Yim; Clifford J Carroll; Ana Tuyama; Natalia Cheshenko; Maria Josefina Carlucci; David D Porter; Gregory A Prince; Betsy C Herold
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.

Authors:  Ayuko Sato; Aldina Suwanto; Manami Okabe; Shintaro Sato; Tomonori Nochi; Takahiko Imai; Naoto Koyanagi; Jun Kunisawa; Yasushi Kawaguchi; Hiroshi Kiyono
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

7.  Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.

Authors:  Andrea S Bertke; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

Review 8.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

9.  Alternative entry receptors for herpes simplex virus and their roles in disease.

Authors:  Joann M Taylor; Erick Lin; Nanette Susmarski; Miri Yoon; Anna Zago; Carl F Ware; Klaus Pfeffer; Jun Miyoshi; Yoshimi Takai; Patricia G Spear
Journal:  Cell Host Microbe       Date:  2007-07-12       Impact factor: 21.023

10.  A neuron-specific role for autophagy in antiviral defense against herpes simplex virus.

Authors:  Brian Yordy; Norifumi Iijima; Anita Huttner; David Leib; Akiko Iwasaki
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.